Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
Market Analysis and Insights: Global Anticancer Drugs Market
The global Anticancer Drugs market size is projected to reach US$ 112910 million by 2027, from US$ 90790 million in 2020, at a CAGR of 3.7% during 2021-2027.
Global Anticancer Drugs Scope and Segment
The global Anticancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
By the end users/application, this report covers the following segments
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other
Competitive Landscape:
The report provides a list of all the key players in the Anticancer Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anticancer Drugs key manufacturers in this market include:
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
Market Analysis and Insights: Global Anticancer Drugs Market
The global Anticancer Drugs market size is projected to reach US$ 112910 million by 2027, from US$ 90790 million in 2020, at a CAGR of 3.7% during 2021-2027.
Global Anticancer Drugs Scope and Segment
The global Anticancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
By the end users/application, this report covers the following segments
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other
Competitive Landscape:
The report provides a list of all the key players in the Anticancer Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anticancer Drugs key manufacturers in this market include:
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
1 Anticancer Drugs Market Overview
1.1 Anticancer Drugs Product Overview
1.2 Anticancer Drugs Market Segment by Type
1.2.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.3 Hormonal Drugs
1.3 Global Anticancer Drugs Market Size by Type
1.3.1 Global Anticancer Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Anticancer Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anticancer Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Type (2016-2021)
2 Global Anticancer Drugs Market Competition by Company
2.1 Global Top Players by Anticancer Drugs Sales (2016-2021)
2.2 Global Top Players by Anticancer Drugs Revenue (2016-2021)
2.3 Global Top Players Anticancer Drugs Price (2016-2021)
2.4 Global Top Manufacturers Anticancer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticancer Drugs Market Competitive Situation and Trends
2.5.1 Anticancer Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticancer Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Anticancer Drugs Market
2.8 Key Manufacturers Anticancer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticancer Drugs Status and Outlook by Region
3.1 Global Anticancer Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anticancer Drugs Historic Market Size by Region
3.2.1 Global Anticancer Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Anticancer Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Anticancer Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anticancer Drugs Forecasted Market Size by Region
3.3.1 Global Anticancer Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Anticancer Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Anticancer Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anticancer Drugs by Application
4.1 Anticancer Drugs Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Breast Cancer
4.1.3 Leukemia
4.1.4 Colorectal Cancer
4.1.5 Other
4.2 Global Anticancer Drugs Market Size by Application
4.2.1 Global Anticancer Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Anticancer Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anticancer Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Application (2016-2021)
5 North America Anticancer Drugs by Country
5.1 North America Anticancer Drugs Historic Market Size by Country
5.1.1 North America Anticancer Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Anticancer Drugs Sales in Value by Country (2016-2021)
5.2 North America Anticancer Drugs Forecasted Market Size by Country
5.2.1 North America Anticancer Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Anticancer Drugs Sales in Value by Country (2022-2027)
6 Europe Anticancer Drugs by Country
6.1 Europe Anticancer Drugs Historic Market Size by Country
6.1.1 Europe Anticancer Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Anticancer Drugs Sales in Value by Country (2016-2021)
6.2 Europe Anticancer Drugs Forecasted Market Size by Country
6.2.1 Europe Anticancer Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Anticancer Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Anticancer Drugs by Region
7.1 Asia-Pacific Anticancer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anticancer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2022-2027)
8 Latin America Anticancer Drugs by Country
8.1 Latin America Anticancer Drugs Historic Market Size by Country
8.1.1 Latin America Anticancer Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anticancer Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Anticancer Drugs Forecasted Market Size by Country
8.2.1 Latin America Anticancer Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anticancer Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Anticancer Drugs by Country
9.1 Middle East and Africa Anticancer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anticancer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anticancer Drugs Business
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Corporation Information
10.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
10.1.5 F. Hoffmann-La Roche Ltd Recent Development
10.2 Eli Lilly and Company
10.2.1 Eli Lilly and Company Corporation Information
10.2.2 Eli Lilly and Company Introduction and Business Overview
10.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
10.2.5 Eli Lilly and Company Recent Development
10.3 CELGENE CORPORATION
10.3.1 CELGENE CORPORATION Corporation Information
10.3.2 CELGENE CORPORATION Introduction and Business Overview
10.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered
10.3.5 CELGENE CORPORATION Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Corporation Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Novartis AG Anticancer Drugs Products Offered
10.4.5 Novartis AG Recent Development
10.5 Pfizer Inc
10.5.1 Pfizer Inc Corporation Information
10.5.2 Pfizer Inc Introduction and Business Overview
10.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Pfizer Inc Anticancer Drugs Products Offered
10.5.5 Pfizer Inc Recent Development
10.6 Amgen Inc
10.6.1 Amgen Inc Corporation Information
10.6.2 Amgen Inc Introduction and Business Overview
10.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Amgen Inc Anticancer Drugs Products Offered
10.6.5 Amgen Inc Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Corporation Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bayer AG Anticancer Drugs Products Offered
10.7.5 Bayer AG Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Corporation Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 AstraZeneca Anticancer Drugs Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Takeda Pharmaceutical Company Limited
10.9.1 Takeda Pharmaceutical Company Limited Corporation Information
10.9.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered
10.9.5 Takeda Pharmaceutical Company Limited Recent Development
10.10 Merck & Co.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anticancer Drugs Product Category, Application and Specification
10.10.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Merck & Co. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticancer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticancer Drugs Industrial Chain Analysis
11.4 Anticancer Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticancer Drugs Distributors
12.3 Anticancer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Anticancer Drugs Product Overview
1.2 Anticancer Drugs Market Segment by Type
1.2.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.3 Hormonal Drugs
1.3 Global Anticancer Drugs Market Size by Type
1.3.1 Global Anticancer Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Anticancer Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anticancer Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anticancer Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Type (2016-2021)
2 Global Anticancer Drugs Market Competition by Company
2.1 Global Top Players by Anticancer Drugs Sales (2016-2021)
2.2 Global Top Players by Anticancer Drugs Revenue (2016-2021)
2.3 Global Top Players Anticancer Drugs Price (2016-2021)
2.4 Global Top Manufacturers Anticancer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticancer Drugs Market Competitive Situation and Trends
2.5.1 Anticancer Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticancer Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Anticancer Drugs Market
2.8 Key Manufacturers Anticancer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticancer Drugs Status and Outlook by Region
3.1 Global Anticancer Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anticancer Drugs Historic Market Size by Region
3.2.1 Global Anticancer Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Anticancer Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Anticancer Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anticancer Drugs Forecasted Market Size by Region
3.3.1 Global Anticancer Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Anticancer Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Anticancer Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anticancer Drugs by Application
4.1 Anticancer Drugs Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Breast Cancer
4.1.3 Leukemia
4.1.4 Colorectal Cancer
4.1.5 Other
4.2 Global Anticancer Drugs Market Size by Application
4.2.1 Global Anticancer Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Anticancer Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anticancer Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anticancer Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Application (2016-2021)
5 North America Anticancer Drugs by Country
5.1 North America Anticancer Drugs Historic Market Size by Country
5.1.1 North America Anticancer Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Anticancer Drugs Sales in Value by Country (2016-2021)
5.2 North America Anticancer Drugs Forecasted Market Size by Country
5.2.1 North America Anticancer Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Anticancer Drugs Sales in Value by Country (2022-2027)
6 Europe Anticancer Drugs by Country
6.1 Europe Anticancer Drugs Historic Market Size by Country
6.1.1 Europe Anticancer Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Anticancer Drugs Sales in Value by Country (2016-2021)
6.2 Europe Anticancer Drugs Forecasted Market Size by Country
6.2.1 Europe Anticancer Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Anticancer Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Anticancer Drugs by Region
7.1 Asia-Pacific Anticancer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anticancer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2022-2027)
8 Latin America Anticancer Drugs by Country
8.1 Latin America Anticancer Drugs Historic Market Size by Country
8.1.1 Latin America Anticancer Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anticancer Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Anticancer Drugs Forecasted Market Size by Country
8.2.1 Latin America Anticancer Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anticancer Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Anticancer Drugs by Country
9.1 Middle East and Africa Anticancer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anticancer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anticancer Drugs Business
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Corporation Information
10.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
10.1.5 F. Hoffmann-La Roche Ltd Recent Development
10.2 Eli Lilly and Company
10.2.1 Eli Lilly and Company Corporation Information
10.2.2 Eli Lilly and Company Introduction and Business Overview
10.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
10.2.5 Eli Lilly and Company Recent Development
10.3 CELGENE CORPORATION
10.3.1 CELGENE CORPORATION Corporation Information
10.3.2 CELGENE CORPORATION Introduction and Business Overview
10.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered
10.3.5 CELGENE CORPORATION Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Corporation Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Novartis AG Anticancer Drugs Products Offered
10.4.5 Novartis AG Recent Development
10.5 Pfizer Inc
10.5.1 Pfizer Inc Corporation Information
10.5.2 Pfizer Inc Introduction and Business Overview
10.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Pfizer Inc Anticancer Drugs Products Offered
10.5.5 Pfizer Inc Recent Development
10.6 Amgen Inc
10.6.1 Amgen Inc Corporation Information
10.6.2 Amgen Inc Introduction and Business Overview
10.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Amgen Inc Anticancer Drugs Products Offered
10.6.5 Amgen Inc Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Corporation Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bayer AG Anticancer Drugs Products Offered
10.7.5 Bayer AG Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Corporation Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 AstraZeneca Anticancer Drugs Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Takeda Pharmaceutical Company Limited
10.9.1 Takeda Pharmaceutical Company Limited Corporation Information
10.9.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered
10.9.5 Takeda Pharmaceutical Company Limited Recent Development
10.10 Merck & Co.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anticancer Drugs Product Category, Application and Specification
10.10.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Merck & Co. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticancer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticancer Drugs Industrial Chain Analysis
11.4 Anticancer Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticancer Drugs Distributors
12.3 Anticancer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
